Sort by
Refine Your Search
-
Employer
- Delft University of Technology (TU Delft)
- Utrecht University
- Wageningen University & Research
- Leiden University
- Naturalis
- University Medical Center Utrecht (UMC Utrecht)
- University of Amsterdam (UvA)
- Eindhoven University of Technology (TU/e)
- Princess Máxima Center for Pediatric Oncology
- Radboud University
- Radboud University Medical Center (Radboudumc)
- Royal Netherlands Academy of Arts and Sciences (KNAW)
- University of Groningen
- University of Twente
- University of Twente (UT)
- 5 more »
- « less
-
Field
-
, long development times, and the risk of toxicity against healthy tissue. At the heart of these challenges lies the TCR specificity problem: understanding how T-cell receptors (TCRs) recognize peptide
-
postdoctoral researcher (0.8 - 1.0 FTE) on Inclusive mobility within BEAT NWO funded research project. Operating from the standpoint that mobility is essentially a subjective human experience, BEAT aims
-
molecular characterization of astroblastoma tumors and developing human brain tissues. You will integrate bulk and single-cell -omics data to identify the molecular consequences of oncogenic fusion genes
-
conduct research on: Repurposing end-of-first-life electric bus and IMC batteries as second-life stationary and mobile energy storage systems with focus on battery degradation and cell-to-cell variations
-
stationary and mobile energy storage systems with focus on battery degradation and cell-to-cell variations Analyzing the impact of battery chemistry, aging history, operational profiles, and pack architecture
-
equivalent) in Biomedical Engineering, Cell Biology, Molecular Biology, Pharmacology, Biochemistry, or closely related fields. Candidates in the final stages of obtaining their degree are eligible to apply
-
We invite highly motivated, independent postdoc candidates with a proven interest and experience in molecular immunology, NK cell biology, and/or human genetics to apply. We positively value
-
street-view imagery (SVIs), geospatial data, mobility data, and qualitative insights to generate evidence-based recommendations for policymakers, planners, and researchers to create healthier urban
-
disease-relevant cellular models of EBV-infected B cells, modulate ERAP2 activity, and read out the downstream consequences for antigen presentation, NK and CD8+ T cell cytotoxicity, and B cell survival
-
for strain improvement. The project will combine cell biology, genome editing and quantitative physiological studies in laboratory bioreactors. The position offers a unique opportunity to work at the interface